Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Song, Moo-Kon; Chung, Joo-Seop; Lee, Gyeong-won; Cho, Su-Hee; Hong, Junshik; Shin, Dong-Yeop; Shin, Ho-Jin
• Is Part Of: Leukemia research. Volume 39:Issue 2(2015:Feb.)
• Page Start: 211
• Page End: 215
• Publication Date: 2015-02
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2014.12.003
• Languages: English
• ISSNs: 0145-2126

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Inhibitory effect of rituximab by statin may be based on ratio of cell-of-origin.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">In our study, non-GC type was found to be more affected by statin use.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">This result reflects that non-GC type might be a beneficiary of R-CHOP therapy.</p> </list-item> </list> </p> </sec> </abstract>